CD11b+/GR1+ MDSCs represent < 3% of all nucleated splenocytes in tumor-free mice, while MDSCs within the spleen expand dramatically to over 20% in tumor-bearing mice [29]. This evidence concerns the gene ITGAM and neoplasm.